Adage Capital Partners Gp, L.L.C. Regulus Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,679,854 shares of RGLS stock, worth $7.87 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,679,854Holding current value
$7.87 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
47Shares Held
36.4MCall Options Held
239KPut Options Held
12.6K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$27.5 Million0.09% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$10.7 Million1.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.27MShares$6.99 Million0.31% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$4.01 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.56MShares$3.34 Million0.37% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $31.3M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...